News | January 29, 2014

Nuke Imaging Tools Tested to Understand Effects of Concussions

Thomas Jefferson University Concussions Nuclear Imaging SPECT
January 29, 2014 — Researchers are seeking to understand what happens inside the living brain after a concussion.  In a study published today in PLOS ONE, researchers at Thomas Jefferson University used single photon emission computed tomography (S.P.E.C.T.) to evaluate two ways to measure physiological brain activity in Traumatic Brain Injury (T.B.I.) patients with chronic, mild symptoms. The findings of their blinded, case-control study are published in an article entitled, Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury. The study included 25 cases and 10 controls.
 
The researchers used S.P.E.C.T. to track cerebral blood flow (C.B.F.), movement of blood through the brain and neurotransmitter dopamine by tracking the binding of a dopamine transporter (D.A.T.) tracer.
 
T.B.I. patients were discovered to have an average of six brain regions with abnormal perfusion, while controls had an average of two abnormal regions (P<0.0001).  Patients with headaches had lower C.B.F. in the right frontal lobe and higher C.B.F. in the left parietal lobe compared to patients without headaches. Lower C.B.F. in the right temporal lobe correlated with poorer reported physical health. Higher D.A.T. binding was associated with more depressive symptoms and overall poorer reported mental health.  However, there was no clear association between C.B.F. and D.A.T. binding in the patients studied.
 
Researchers concluded that S.P.E.C.T. imaging of D.A.T. and C.B.F. were useful tools that provide distinct information about brain physiology after T.B.I.
 
For more information: www.jefferson.edu

Related Content

PET Tracer Gauges Effectiveness of Promising Alzheimer's Treatment

Longitudinal PET imaging with 18F-AV45. PET imaging shows the average 18F-AV45 uptake per animal group at 8 and 13 months of age. A significant interaction of genotype treatment was observed in the cortex (p = 0.0248), hippocampus (p = 0.0071) and thalamus (p = 0.0084), indicating reduced [18F]-AV45 uptake in BACE1 inhibited transgenic mice. Credit: MICA, University of Antwerp, Belgium.

News | Radiopharmaceuticals and Tracers | December 28, 2017
In the December featured basic science article in The Journal of Nuclear Medicine, Belgian researchers report on the...
Vital Unveils Newest Vitrea Advanced Visualization Release at RSNA 2017
Technology | Advanced Visualization | December 04, 2017
Vital Images unveiled the newest version of Vitrea Advanced Visualization software, the cornerstone of its imaging...
Michael J. Fox Foundation and Tau Consortium Developing PET Tracers for Neurodegenerative Disease
News | Radiopharmaceuticals and Tracers | October 27, 2017
The Michael J. Fox Foundation for Parkinson's Research (MJFF) and the Tau Consortium announced a funding partnership to...
Netherlands Cancer Institute Exploring Molecular Imaging Technology for Prostate Cancer Surgery
News | Molecular Imaging | October 26, 2017
The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer Society (KWF...
SNMMI Publishes New FDG PET/CT Appropriate Use Criteria
News | PET-CT | October 25, 2017
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/...
Biodex Unveils Atomlab 500 Dose Calibrator and Wipe Test Counter
Technology | Nuclear Imaging | October 19, 2017
Biodex Medical Systems announced the full release of the Atomlab Dose Calibrator and Wipe Test Counter to the market...
ASNC and ASE Team Up to Expand ImageGuide Registry
News | Cardiovascular Ultrasound | October 12, 2017
The American Society of Nuclear Cardiology (ASNC) and the American Society of Echocardiography (ASE) jointly announced...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI) | October 11, 2017
October 11, 2017 — MR Solutions took their cryogen-free preclinical multimodality...
Majority of Recurrent Prostate Cancer Patients' Treatment Plan Changed Following Fluciclovine 18F PET/CT
News | Prostate Cancer | October 04, 2017
Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an investigational...
News | Business | September 19, 2017
September 19, 2017 — Invicro LLC, a provider of imaging services and software for research and drug development, anno
Overlay Init